Bitdeer Announces Pricing of Registered Direct Offering of 10,661,140 Class A Ordinary Shares

(NASDAQ:BTDR), SINGAPORE, Nov. 13, 2025 (GLOBE NEWSWIRE) — Bitdeer Technologies Group (Nasdaq: BTDR) (“Bitdeer“), a world-leading technology company for Bitcoin mining and AI cloud, today announced the pricing of its registered direct offering of 10,661,140 of its Class A ordinary shares, par value US$0.0000001 per share (the “Class A ordinary shares“), to certain holders of […]

Bitdeer Announces Pricing of US$400.0 Million Convertible Senior Notes Offering

(NASDAQ:BTDR), SINGAPORE, Nov. 13, 2025 (GLOBE NEWSWIRE) — Bitdeer Technologies Group (Nasdaq: BTDR) (“Bitdeer“), a world-leading technology company for Bitcoin mining and AI cloud, today announced the pricing of US$400.0 million principal amount of 4.00% Convertible Senior Notes due 2031 (the “notes“) in a private placement (the “notes offering“) to persons reasonably believed to be

Bondex Now Controls Over Half of Web3 Job Traffic after Acquisition of Remote3

LONDON, Nov. 13, 2025 (GLOBE NEWSWIRE) — Bondex, the Web3 platform revolutionizing professional trust and credibility, has announced the acquisition of Remote3, a leading remote job board for developers, community managers, designers, and non-technical professionals in the crypto industry. This marks Bondex's second major acquisition in the job board space following that of Web3.Career this

Rumble Cloud Partners with the Cleveland Browns

(NasdaqGM:RUM), LONGBOAT KEY, FL, Nov. 13, 2025 (GLOBE NEWSWIRE) — Rumble (NASDAQ:RUM), the video-sharing platform and cloud services provider, today announced a partnership with the Cleveland Browns to provide the infrastructure services of the Rumble Cloud. As part of the agreement, Rumble will provide video cloud storage for the Browns. “When you're running a football

ECGI Appoints AI Platform Architect as CTO to Build Mortgage Tokenization Infrastructure

(PinkSheets:ECGI),(Pinksheets:ECGI), IRVINE, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) — ECGI Holdings, Inc. (OTC:ECGI) announced today that Mandeep Singh has been appointed Chief Technology Officer to spearhead the design and deployment of the company's AI-driven mortgage tokenization infrastructure. Singh will architect the platform that powers ECGI's next phase of technology expansion, including real-time asset intelligence and

Champion Safe Highlights Explosive 92% Year-to-Date Growth at SafeSource Pennsylvania

(NASDAQ:AREB),(NASDAQ:AREBW), Acquisition of Champion's Lewisberry, PA Location Drives Major Expansion for Northeast Retailer Provo, UT, Nov. 13, 2025 (GLOBE NEWSWIRE) — Champion Safe Company (championsafe.com), a premier manufacturer of high-security safes and a proud subsidiary of American Rebel Holdings, Inc. (NASDAQ: AREB), America's Patriotic Brand, proudly recognizes SafeSource USA for its outstanding 92% year-to-date growth

Draganfly Secures Second Major Order from Fortune 50 Telecommunications Company to Expand NDAA-Compliant Heavy Lift Drone Fleet

(NASDAQ:DPRO),(Boerse Berlin – Freiverkehr:3U8A.BE),(CNSX:DPRO.CN),(Boerse Frankfurt – Freiverkehr:3U8A),(Frankfurt:3U8A.F),(CNSX:DPRO),(Boerse Frankfurt – Freiverkehr:3U8), Tampa Bay, Florida, Nov. 13, 2025 (GLOBE NEWSWIRE) — Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer, today announced a second purchase order (“PO”) from a Fortune 50 telecommunications company. Under this agreement,

Tiziana Life Sciences to Present at Jefferies Global Healthcare Conference

(NASDAQ:TLSA), BOSTON, Nov. 13, 2025 (GLOBE NEWSWIRE) — Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, today announced that its senior leadership team will present at the prestigious Jefferies London Healthcare Conference. Chief

Fate Therapeutics Reports Third Quarter 2025 Financial Results and Business Updates

(NasdaqGM:FATE), Authorization Received from UK and EU Authorities to Activate ex-US Clinical Trial Sites Supporting the Ongoing Patient Enrollment of FT819, an Off-the-Shelf CD19-targeted CAR T-cell Product Candidate that Utilizes Less-intensive or No Conditioning, Enabling Broad Patient Accessibility First Systemic Sclerosis Patient treated in Phase 1 Study of FT819 Following Fludarabine-free Conditioning; Dose Expansion Designed

AEON Biopharma Announces Fundraise Totaling Up to ~$22 Million through Private Placement and Proposed Exchange of Daewoong Convertible Notes

– Combined transactions will strengthen balance sheet and reduce outstanding debt by more than 90% – – $6 million PIPE financing with potential for over $7 million of additional capital via cash-exercise warrants – – Daewoong has entered binding term sheet for exchange of $15 million of notes plus accrued interest into equity, $1.5 million

Scroll to Top